tiprankstipranks
Trending News
More News >
Tevogen Bio Holdings (TVGN)
NASDAQ:TVGN
US Market

Tevogen Bio Holdings (TVGN) Income Statement

Compare
322 Followers

Tevogen Bio Holdings Income Statement

Last quarter (Q3 2025), Tevogen Bio Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Tevogen Bio Holdings's net income was $-5.73M. See Tevogen Bio Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -403.58K$ -378.36K$ 0.00$ 0.00
Operating Expenses
$ 53.16M$ 8.46M$ 953.08K$ 4.62M
Depreciation and Amortization
$ 403.58K$ 378.36K$ 0.00$ 9.38K
EBITDA
$ -13.14M$ -58.89M$ 4.41M$ -14.99M
Operating Income
$ -53.56M$ -8.84M$ -953.08K$ -4.62M
Other Income/Expenses
$ 39.84M$ -51.63M$ 5.36M$ -10.98M
Pretax Income
$ -13.73M$ -60.48M$ 4.41M$ -15.60M
Net Income
$ -10.11M$ -60.48M$ 4.41M$ -15.60M
Per Share Metrics
Basic EPS
$ -0.09$ 0.00$ 0.04$ -0.33
Diluted EPS
$ -0.09$ 0.00$ 0.04$ -0.33
Weighted Average Shares Outstanding
146.67M 165.42M 120.00M 47.93M
Weighted Average Shares Outstanding (Diluted)
146.67M 165.42M 120.00M 47.93M
Currency in USD

Tevogen Bio Holdings Earnings and Revenue History